Delivery Order SPE2DB20D3103-SPE2DB24FP9J2

Award Date 8/16/24
Potential Completion Date 9/9/24
Potential Value $68K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $22,652.90. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,780.96 and is a firm fixed-price delivery order with a completion date of June 8, 2023. The contract is not designated as a set-aside and was awarded through full and open...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,780.96 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 27, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,122.40, is a Firm Fixed Price Delivery Order with a completion date of June 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $7,030.77 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 10, 2024, with a completion date of January 2, 2025. The contract is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,374.36 firm fixed-price contract was awarded on December 18, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of January 10, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the procurement of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML pharmaceuticals. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $61,162.83 with a firm fixed price and an ultimate completion date of August 27, 2024. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products. The contract, valued at $2,343.59, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price delivery order with a performance period through June 12, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,265.29 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 6, 2024. The contract has an ultimate completion date of September 27, 2024 and does not utilize a set-aside. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the Defense Logistics Agency (DLA). The $7,030.77 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 26, 2025, with a completion date of March 19, 2025. The contract is a delivery order under an Indefinite Delivery Contract valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP9J2
    Delivery Order

This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $67,958.70 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 9, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 1:28 PM